Can a meta-analysis that included articles with high heterogeneity appropriately evaluate the risk of venous thromboembolism in users of combined hormonal contraceptives containing drospirenone or desogestrel? A reply to Rosa et al.

Francisca Martínez *Servicio de Medicina de la Reproducción, Institut Universitari Dexeus, Barcelona

Kepa LatorreUnidad de Investigación de Atención Primaria de Bizkaia, Bilbao

Isabel RamírezServicio de Salud Sexual y Reproductiva, UGC Cayetano Roldan, San Fernando, Cádiz

Ezequiel Pérez-CamposServicio de Ginecología, Hospital de Requena, Valencia

Iñaki LeteServicio de Ginecología, Hospital Santiago, Vitoria, Spain

Click to increase image sizeClick to decrease image size

Declaration of interest: FM, IR, EP-C and IL have received fees for services rendered to pharmaceutical firms producing hormonal contraceptives. The authors alone are responsible for the content and the writing of the paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Can a meta-analysis that included articles with high heterogeneity appropriately evaluate the risk of venous thromboembolism in users of combined hormonal contraceptives containing drospirenone or desogestrel? A reply to Rosa et al.

Information for

Open access

Opportunities

Help and information

Can a meta-analysis that included articles with high heterogeneity appropriately evaluate the risk of venous thromboembolism in users of combined hormonal contraceptives containing drospirenone or desogestrel? A reply to Rosa et al.

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature